Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. E.S. Doherty, F.L. Lacbawan 2q37, Microdeletion Syndrome. In: Adam M., Mirzaa G., Pagon R., Al E., editors. GeneReviews. Seattle, WA: University of Washington; 2007.
2. A. Arefzadeh, P. Khalighinejad, B. Ataeinia, P. Parvar, Brachydactyly mental retardation syndrome with growth hormone deficiency. Endocrinol. Diabetes Metab. Case Rep. 2018, 18–0068 (2018)
3. F.M. Elli, L. Desanctis, M.A. Maffini, P. Bordogna, D. Tessaris, A. Pirelli et al. Association of GNAS imprinting defects and deletions of chromosome 2 in two patients: Clues explaining phenotypic heterogeneity in pseudohypoparathyroidism type 1B/iPPSD3. Clin. Epigeneti. 11, 1–8 (2019)
4. F.M. Elli, L. de Sanctis, B. Madeo, M.A. Maffini, P. Bordogna, A. Pirelli et al. 2q37 deletions in patients with an albright hereditary osteodystrophy phenotype and PTH resistance. Front. Endocrinol. 10, 1–7 (2019)
5. M.M. Power, R.S. James, J.C.K. Barber, A.M. Fisher, P.J. Wood, B.A. Leatherdale et al. RDCI, the vasoactive intestinal peptide receptor: A candidate gene for the features of Albright hereditary osteodystrophy associated with deletion of 2q37. J. Med. Genet. 34, 287–290 (1997)